IRIS
SERTOLI, MARIO ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.128
Totale 5.128
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.128
Totale 5.128
Salva come PNG Salva come JPEG
Città #
Genova 4.229
Rapallo 556
Genoa 338
Bordighera 5
Totale 5.128
Salva come PNG Salva come JPEG
Nome #
Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors. 152
Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review. 143
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 142
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years 139
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 130
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. 129
Phase II study with high-dose N5-10-methyltetrahydrofolate and 5-fluorouracil in advanced colorectal cancer. 127
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. 127
Gene-expression profiling in vaccine therapy and immunotherapy for cancer. 125
"Autologous Bone Marrow Transplantation for Adult Advanced Stage Lymphoblastic Lymphoma in First CR. A Study of the NHLCSG". 121
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 117
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial 112
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials 112
Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial. 110
Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial 108
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. 105
Heat shock proteins and their use as anticancer vaccines. 105
Improved chopping of a lithium beam for plasma edge diagnostic at ASDEX Upgrade. 104
Combination of sorafenib and weekly gemcitabine in patients (pts) with metastatic renal cell Cancer (MRCC): A phase II study, preliminary results 103
84: [Antibiotic preparation in operations on the large intestine. Experimental study] GF, Rollandi GA. 102
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis 102
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. 101
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 100
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 100
Randomized cooperative study of perioperative chemotherapy in breast cancer. 99
High prevalence of the G101W germline mutation in the CDKN2A (P16INK4A) gene in 62 Italian malignant melanoma families 97
INK4/ARF germline alterations in pancreatic cancer patients 96
Fattibilità della Terapia Adiuvante Intraperitoneale e Sistemica in Pazienti Operati Radicalmente per Carcinoma del Colon. 95
Radiation-associated angiosarcoma: diagnostic and therapeutic implications--two case reports and a review of the literature. 95
Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma. 95
Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2 94
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials 89
VACOP-B Versus VACOP-B Plus Autologous Bone Marrow Transplantation for Advanced Diffuse Non-Hodgkin's Lymphoma: Results of a Prospective Randomized Trial by the Non-Hodgkin's Lymphoma Cooperative Study Group 87
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 87
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 83
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials 83
Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. 81
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. 78
Impaired Humoral Response to Influenza Vaccine and Prolonged B Memory Cell Depletion as a Consequence of Rituximab-based Immunochemotherapy in non-Hodgkin Lymphoma Patients 78
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG 76
Intrahepatic epidoxorubicin in metastatic and primary liver tumours: a phase II study. 75
[Antibiotic preparation in operations on the large intestine. Experimental study]. 72
Intraperitoneal infusion of recombinant interleukin-2 in malignant ascites in patients with gastrointestinal and ovarian cancer. 69
INK4/ARF germline mutations and additional neoplasia in pancreatic cancer patients and their families 69
Phenotypic and functional characteristics of tumor-associated lymphocytes in patients with malignant ascitis receiving intraperitoneal infusions of recombinant interleukin-2 (rIL-2) 67
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma 65
Second-line hormonotherapy for breast cancer. Uselessness of first-line continuation. 62
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma. 59
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial 59
La preparazione antibiotica negli interventi sul grosso intestino 56
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group. 54
Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective. 52
Merkel cell carcinoma of the skin. Treatment of primary, recurrent and metastatic disease: review of clinical cases. 52
Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori Group. 51
La preparazione antibiotica negli interventi sul grosso intestino. Studio sperimentale 43
Mutazioni germinali al locus INK4/ARF in pazienti affetti da adenocarcinoma pancreatico in relazione alla storia oncologica familiare 37
A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer 10
Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer 6
Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy 3
Totale 5.190
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.793
article - articoli 13.650
book - libri 0
conference - conferenze 143
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.586
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019307 0 0 0 0 0 0 0 0 0 0 165 142
2019/20201.546 70 47 57 108 144 177 237 104 131 257 158 56
2020/2021383 24 42 23 36 33 41 28 33 33 44 22 24
2021/2022659 14 43 43 99 23 53 32 166 25 66 14 81
2022/2023655 63 56 5 79 113 114 6 41 112 1 57 8
2023/2024247 15 48 10 45 24 37 14 25 18 11 0 0
Totale 5.190